H扫描超声监测乳腺癌化疗反应并与扩散加权MRI验证
该临床前研究纳入18只人乳腺癌细胞移植雌鼠,在化疗后多个时间点行三维H扫描超声与扩散加权MRI成像,发现H扫描超声可早期检测肿瘤细胞凋亡相关的散射体尺寸变化,且与ADC值呈强线性相关。H扫描超声有望辅助监测乳腺癌新辅助化疗的早期反应。
要点
- H扫描超声可早期检测乳腺癌化疗后细胞凋亡相关散射体尺寸变化
- H扫描超声纵向变化与DW-MRI及纹理分析结果一致
- H扫描图像强度与DW-MRI的ADC值呈强线性相关
关键影像表现/征象
- 低剂量和高剂量顺铂治疗组H扫描超声图像强度变化提示聚集超声散射体尺寸进行性减小,对照组未见此变化。
- H扫描超声的纵向变化趋势与纹理分析及DW-MRI结果匹配(P < .01)。
- H扫描超声图像强度与对应DW-MRI衍生的ADC值呈强线性相关(R2 = .93,P < .001)。
- 这些变化归因于癌细胞凋亡活性,被认为是治疗期间可早期检测的生物标志物。
临床应用与阅片要点
- H扫描超声可作为监测乳腺癌新辅助化疗早期反应的辅助手段,补充传统诊断超声。
- 阅片时关注H扫描图像强度变化及散射体尺寸的进行性减小趋势。
- 可将H扫描结果与DW-MRI的ADC值对照,两者高度相关。
局限性
- 研究为动物实验(裸鼠模型),样本量较小(N = 18),结论外推至临床需谨慎。
- 仅评估顺铂诱导凋亡模型,未涉及其他化疗药物或方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: H-scan ultrasound (US) imaging is a novel tissue characterization technique to detect apoptosis-induced changes in cancer cells after the initiation of effective drug treatment. The objective of the proposed research was to assess the sensitivity of 3-dimensional (3D) H-scan US technique for monitoring the response of breast cancer-bearing animals to neoadjuvant chemotherapy and correlate results to diffusion-weighted magnetic resonance imaging (DW-MRI) measurements of programmed cancer cell death.
METHODS: Experimental studies used female mice (N = 18) implanted with human breast cancer cells. Animals underwent H-scan US and DW-MRI imaging on days 0, 1, 3, 7, and 10. After imaging at day 0, breast tumor-bearing nude mice were treated biweekly with an apoptosis-inducing drug. Texture analysis of H-scan US images explored spatial relationships between local US scattering. At day 10, H-scan measurements were compared with DW-MRI-derived apparent diffusion coefficient (ADC) values and histological findings.
RESULTS: H-scan US imaging of low and high dose cisplatin-treated cancer-bearing animals revealed changes in image intensity suggesting a progressive decrease in aggregate US scatterer size that was not observed in control animals. Longitudinal trends discovered in H-scan US result matched with texture analysis and DW-MRI (P < .01). Further, analysis of the H-scan US image intensity and corresponding DW-MRI-derived ADC values revealed a strong linear correlation (R2 = .93, P < .001). These changes were due to cancer cell apoptotic activity and consider as early detectable biomarker during treatment.
CONCLUSIONS: The 3D H-scan technique holds promise for assisting clinicians in monitoring the early response of breast cancer tumor to neoadjuvant chemotherapy and adding value to traditional diagnostic ultrasound examinations.
引用
- Tai, Margolis, Li, et al. H-Scan Ultrasound Monitoring of Breast Cancer Response to Chemotherapy and Validation With Diffusion-Weighted Magnetic Resonance Imaging. J Ultrasound Med. 2022. PMID: 36468546. doi:10.1002/jum.16143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。